Skip to main content

Thursday, November 21, 2024 11/21/2024

Investigating the therapeutic potential of a novel glutamine antagonist in KEAP1 mutant lung cancer

Award Number: R01CA262562
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract


	Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

	Issue Date FY: 2025 ( Subtotal = $589,932 )
	2025	2025	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Cancer Treatment Research	000	2	11/15/2024	NON-COMPETING CONTINUATION	$589,932
															Subtotal = $589,932

	Issue Date FY: 2024 ( Subtotal = $672,853 )
	2024	2024	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Cancer Treatment Research	000	1	12/19/2023	NEW	$672,853
															Subtotal = $672,853

	Grand Total All Awards = $1,262,785

Hide

Top